UroGen Pharma Ltd. (URGN) › Total AssetsUroGen Pharma Ltd. (URGN) — Total AssetsAnnual figures by period end, from SEC filings.2016-12-31: $23.06M2017-12-31: $75.55M2018-12-31: $103.56M2019-12-31: $202.39M2020-12-31: $122.00M2021-12-31: $119.75M2022-12-31: $135.62M2023-12-31: $178.31M2024-12-31: $285.71M2025-12-31: $200.46M$200.46M2016-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$200.46M-29.8%2026-03-02Balance as of period end2024-12-31$285.71M+60.2%2026-03-02Balance as of period end2023-12-31$178.31M+31.5%2025-03-10Balance as of period end2022-12-31$135.62M+13.3%2024-03-14Balance as of period end2021-12-31$119.75M-1.9%2023-03-24Balance as of period end2020-12-31$122.00M-39.7%2022-03-21Balance as of period end2019-12-31$202.39M+95.4%2021-03-18Balance as of period end2018-12-31$103.56M+37.1%2020-03-02Balance as of period end2017-12-31$75.55M+227.7%2019-02-28Balance as of period end2016-12-31$23.06M—2018-03-15Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)